Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Assets (2019 - 2025)

Historic Return on Assets for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to 0.23%.

  • Arcturus Therapeutics Holdings' Return on Assets fell 600.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.21% for FY2024, which is 1400.0% down from last year.
  • Arcturus Therapeutics Holdings' Return on Assets amounted to 0.23% in Q3 2025, which was down 600.0% from 0.19% recorded in Q2 2025.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Return on Assets peaked at 0.24% during Q1 2023, and registered a low of 0.53% during Q1 2022.
  • In the last 5 years, Arcturus Therapeutics Holdings' Return on Assets had a median value of 0.23% in 2025 and averaged 0.2%.
  • In the last 5 years, Arcturus Therapeutics Holdings' Return on Assets surged by 7800bps in 2023 and then plummeted by -5000bps in 2024.
  • Arcturus Therapeutics Holdings' Return on Assets (Quarter) stood at 0.49% in 2021, then skyrocketed by 106bps to 0.03% in 2022, then plummeted by -336bps to 0.07% in 2023, then crashed by -238bps to 0.23% in 2024, then grew by 0bps to 0.23% in 2025.
  • Its Return on Assets was 0.23% in Q3 2025, compared to 0.19% in Q2 2025 and 0.2% in Q1 2025.